Orrick Advises COVA Acquisition on $3.82 Billion SPAC Merger with ECARX

1 minute read | December.20.2022

Orrick is advising COVA Acquisition Corp., a special purpose acquisition company, on its definitive agreement to merge with mobility tech company ECARX Holdings. The business combination closed on December 20, 2022, upon which ECARX shares and warrants began trading on the Nasdaq under the ticker symbols ECX and ECXWW, respectively.

Proceeds from the transaction will be used to accelerate ECARX’s technology development and the roll-out of new products, support strategic acquisitions or investments, as well as create further pathways for global growth.

The Orrick team advising COVA Acquisition is led by Albert Vanderlaan and Hari Raman and includes Jeff Zhang, Brian Blood, Travis Cherry, Sami Ghubril, Tom Sanford, Martha Wang, Shelley Zhang, Yali Hu, Yuan Tian, Peter Elias, Sarah Schaedler, Steven Malvey, Shannon Yavorsky, Asami Ono, Daniel Healow, Daniel Kearney, Matthew Coleman, Michael Wiesner, Amber Zhou, Maria Sergeyeva, Jeanine McGuinness, Milana Karayanidi, Jennifer Criss, and Matthew Rose.

Related Lawyers

Albert Vanderlaan Partner, Capital Markets, Corporate Governance

Boston

See my bio

D:+1 617 880 2219
E: [email protected]

Practice:

Technology & Innovation Sector
Capital Markets
Corporate Governance
Technology Companies Group
Life Sciences
Special Purpose Acquisition Companies (SPACs)
Mergers & Acquisitions

vCard

See full bio

Albert Vanderlaan Partner

Boston

Albert is involved in a broad range of corporate legal engagements for high growth technology companies, including IPOs, follow-on public offerings, private and public company securities law compliance matters, public company disclosure obligations, de-SPAC transactions, SPAC IPOs, venture financings and mergers and acquisitions. He also regularly advises public and private companies and their boards of directors on corporate governance issues.

Albert's clients include public and private companies in technology, automotive, Internet related industries, real estate, finance and the life sciences (including, among others, immuno-oncology, gene therapy, restorative cell therapy and medical device companies). He also represents underwriters in initial public offerings, follow-on offerings and PIPE offerings and venture capital firms in a variety of investment transactions.

Albert was named to the Deal’s Top Rising Stars 2021 list, which recognizes top new partners at U.S. law firms who are “doing spectacular work in the field of deal-making and who have continued to progress in their career despite the obstacles put in front of them.”

Hari Raman Partner, Mergers & Acquisitions, Special Purpose Acquisition Companies (SPACs)

San Francisco

See my bio

D:+1 415 773 4223
E: [email protected]

Practice:

Mergers & Acquisitions
Special Purpose Acquisition Companies (SPACs)

vCard

See full bio

Hari Raman Partner

San Francisco

Hari represents private equity firms and public, private, emerging and late-stage technology companies in a variety of domestic and international transactions. His experience spans the range of M&A activity, including cross-border deals, SPAC transactions, majority/minority investments, restructurings and general corporate matters. He works closely with serial acquirers implementing their buy-side M&A strategies, and with venture-backed companies, founders and investors in M&A exits and other liquidity transactions.

Hari has extensive experience leading companies in core technology markets through all aspects of the M&A process. He understands the unique issues, deal terms and trends at play in technology M&A, allowing him to optimize for efficiency, transaction execution and results for his clients.

Hari has also previously worked in Asia and the Middle East on complex, cross-border M&A, and leverages that experience in leading M&A transactions across the globe, including China, India, Israel and the United Kingdom.

Prior to joining Orrick, Hari was an associate at Gibson, Dunn & Crutcher LLP. He is qualified to practice in both California and New York.

Related Areas

Special Purpose Acquisition Companies (SPACs)